Tuesday, 23 November 2021

U.S. Revenue Cycle Management Market Set to Surge Significantly During 2021-2028: Grand View Research Inc.

 U.S. Revenue Cycle Management Market Growth & Trends

The U.S. revenue cycle management market size is projected to reach USD 286.7 billion by 2028, according to a new report by Grand View Research, Inc. This market is expected to expand at a CAGR of 11.2% over the forecast period. An increase in pressure on healthcare providers to implement revenue cycle management (RCM) solutions, the rise in adoption of Consumer-driven Healthcare (CDH) accounts, and growth in the number of collaborations in the market are the major factors driving the industry growth.

The integrated product type segment accounted for the largest revenue share of over 70% in 2020 and is expected to grow at the fastest CAGR over the forecast period. These systems provide seamless access to clinical data from Electronic Health Records (EHRs) and similar databases. For instance, according to a news article published by Cerner Corp. in 2020, fully integrated EHR systems provided by the company are proving to be beneficial and providing improvements in the RCM systems at the San Juan Regional Medical Center. Hence, the rising adoption of integrated systems is likely to fuel the segment growth during the forecast period.

On the basis of delivery mode, the web-based segment accounted for the highest revenue share in 2020. Key factors responsible for this growth included affordability, rapid Return on Investment (RoI), and ease of deployment of these systems. On the other hand, the cloud-based segment is expected to grow at the fastest CAGR over the forecast period. Based on sourcing, the outsourcing segment is expected to register the fastest growth rate over the forecast period. There is a rise in the demand for services outsourcing during the Covid-19 pandemic owing to the rapidly increasing inpatient volume, claim fluctuations and staff productivity.

Request a free sample copy or view report summary: U.S. Revenue Cycle Management Market Report

U.S. Revenue Cycle Management Market Report Highlights

  • The market was valued at USD 120.7 billion in 2020 and is anticipated to grow at a CAGR of 11.2% over the forecast period
  • In 2020, the services segment is predicted to account for the largest market share growing at the fastest CAGR from 2021 to 2028
  • This growth is credited to the increased demand for service outsourcing due to the dearth of skilled labor, shortage of resources, and rising healthcare costs in the U.S.
  • The software segment is also projected to witness significant growth over the forecast period owing to the rising adoption and penetration of software-based solutions in the market
  • In 2020, the integrated systems product type segment accounted for the largest revenue share owing to the increasing demand for these systems to eliminate human errors and speeding up the administrative functions

Access Press Release@ https://www.grandviewresearch.com/press-release/us-revenue-cycle-management-rcm-market-analysis

U.S. Revenue Cycle Management Market Segmentation

Grand View Research has segmented the U.S. revenue cycle management market on the basis of end user, product type, component, delivery mode, physician specialty, sourcing, and functions:

U.S. RCM End-user Outlook (Revenue, USD Billion, 2016 - 2028)

  • Hospitals
  • Physician & Clinical Services

U.S. RCM Product Type Outlook (Revenue, USD Billion, 2016 - 2028)

  • Integrated System
  • Standalone System

U.S. RCM Component Outlook (Revenue, USD Billion, 2016 - 2028)

  • Software Solution
  • Services

U.S. RCM Delivery Mode Outlook (Revenue, USD Billion, 2016 - 2028)

  • On-premise
  • Web-based
  • Cloud-based

U.S. RCM Physician Specialty Outlook (Revenue, USD Billion, 2016 - 2028)

  • Oncology
  • Cardiology
  • Anesthesia
  • Radiology
  • Pathology
  • Pain Management
  • Emergency Services
  • Others

U.S. RCM Sourcing Outlook (Revenue, USD Billion, 2016 - 2028)

  • In-house
  • External Apps/Software
  • Outsourced Services

U.S. RCM Functions Outlook (Revenue, USD Billion, 2016 - 2028)

  • Product Development
  • Member Engagement
  • Network Management
  • Care Management
  • Claim Management
  • Risk and Compliances

List of Key Players of U.S. Revenue Cycle Management (RCM) Market

  • The SSI Group, Inc.
  • McKesson Corp.
  • AllScripts Healthcare, LLC
  • Athenahealth, Inc.
  • Epic Systems Corp.
  • NXGN Management, LLC
  • Oncospark, Inc.
  • eClinicalWorks

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Consumer Genomics Market Projected To Be Worth USD 8.1 Billion By 2028: Grand View Research Inc.

 Consumer Genomics Market Growth & Trends

The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Technological advances in genetic research have helped to raise awareness among physicians as well as consumers pertaining to the use of gene-based testing.

Genomics testing enables the determination of common traits by studying a DNA molecule, predictions about health, and offers evidence of a person’s ancestry. Several companies are providing DNA tests directly to customers by which they have access to their genetic information without involving the healthcare professional. Rising awareness about DNA testing has driven the adoption rate, which in turn provides healthy growth prospects for the implementation of DNA tests in home settings.

The continuously declining costs of genotyping have resulted in direct-to-consumer services becoming more accessible to the average consumer as DNA testing services are delivered by key companies. Many key participants are focusing majorly on building partnerships and collaborations with physicians and healthcare systems to inflate their current marketplace.

Request a free sample copy or view report summary: Consumer Genomics Market Report

Consumer Genomics Market Report Highlights

  • The genetic relatedness segment accounted for the largest revenue generation in 2020 and is anticipated to remain dominant throughout the forecast period
  • Genetic relatedness involves the determination of hereditary or the genetic transfer of traits from parents to their offspring
  • These tests help analyze repetitive DNA regions known as short tandem repeats for the determination of a likelihood of paternity
  • The lifestyle, wellness, and nutrition segment is expected to witness the fastest CAGR as consumer genomics tests are claimed to provide personalized nutrition based on an individual’s genotype
  • For patients with rare genetic disorders such as galactosemia and lactose intolerance, a customized diet is recommended
  • Growing public interest for personalized health has fueled the adoption of nutrigenetic testing services, specifically for optimizing nutrition
  • Hence, personalized nutrition is employed to maintain or improve health by using genetic, clinical, and dietary information to provide precise and more efficacious personalized healthy recommendations
  • North America is estimated to capture the largest market share owing to the local presence of key industry participants such as 23andMe and AncestryDNA, and the commercialization of FDA approved kits 
  • Due to growing investments and skills, in Asia Pacific, the market is expected to grow with the fastest CAGR
  • This can majorly be attributed to the advent of knowledge-based innovations and entry of investors focused on personalized genetic screening as well as the presence of research funding agencies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-consumer-genomics-market

Consumer Genomics Market Segmentation

Grand View Research has segmented the global consumer genomics market on the basis of application and region:

Consumer Genomics Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, & Nutrition
  • Ancestry
  • Reproductive Health
  • Personalized Medicine & Pharmacogenetic testing
  • Sports Nutrition & Health
  • Others

Consumer Genomics Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia

List of Key Players of Consumer Genomics Market

  • Ancestry
  • Gene By Gene, Ltd. (FamilyTree DNA)
  • 23andMe, Inc.
  • Color Genomics, Inc
  • Myriad Genetics, Inc
  • Mapmygenome
  • Positive Biosciences, Ltd
  • Futura Genetics
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Pathway Genomics
  • Veritas
  • Amgen, Inc.
  • Xcode Life
  • Diagnomics, Inc.
  • Toolbox Genomics
  • SomaLogic, Inc.
  • inui Health (formerly Scanadu)
  • AgeCurve
  • QuickCheck Health
  • Biomeb
  • Metabolomic Discoveries GmbH
  • Illumina, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Laboratory Information Management System Market Will See Strong Expansion Through 2028: Grand View Research Inc.

 Laboratory Information Management System Market Growth & Trends

The global laboratory information management system market size is expected to reach USD 1.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.0% from 2021 to 2028. Factors contributing to the growth of the laboratory information management system (LIMS) market include growing demand for laboratory automation, investments in life sciences industry, demand for outsourcing, and technological advancements.

To help in tackling the effect of COVID-19, market players aimed at launching novel solutions in the market. For instance, LabVantage launched the COVID-19 LIMS which is helpful in managing the unprecedented acceleration of the laboratory workflow and volume due to the pandemic. Likewise, in March 2020, Ovation, a U.S. based startup launched an initiative that was centered on its cloud-based LIMS and was aimed towards enabling independent laboratories to broaden their capabilities and effectively doubling the testing capacity throughout the country.

Increasing investment in R&D sectors by pharma and biotechnological organizations is another factor propelling the growth of laboratory information management system. According to National Science Foundation (NSF) data in 2018, the spending on R&D has been increased by approximately 3.2% between 2015 and 2017. Increase in demand for laboratory automation is expected to fuel market growth.

Request a free sample copy or view report summary: Laboratory Information Management System Market Report

Laboratory Information Management System Market Report Highlights

  • The cloud-based segment dominated the market and accounted for the largest revenue share in 2020. The segment is projected to show a CAGR of over 4.6% from 2021 to 2028. Technological advancements by market players are expected to drive the segment
  • The services component segment accounted for the largest revenue share owing to the rising lab automation which required implementation, maintenance, and support
  • North America held the largest revenue share in 2020, due to the favorable government initiatives, demand for genomic studies, and increased investment in R&D by the government
  • The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge
  • The CRO segment is expected to exhibit the lucrative CAGR of 4.6% due to increasing demand for outsourcing LIMS solutions to curb the operating cost
  • In Asia Pacific, the market is anticipated to witness lucrative growth of around 5.4% owing to the rising demand for outsourcing and increasing expenditure in the R&D sector
  • In February 2020, LabVantage Solutions announced the availability of a SaaS package for its purpose-built LIMS platform

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laboratory-information-management-system-lims-market

Laboratory Information Management System Market Segmentation

Grand View Research has segmented the global laboratory information management system market on the basis of product, component, end-use, and region:

LIMS Product Outlook (Revenue, USD Million, 2016 - 2028)

  • On-premise
  • Web-hosted
  • Cloud-based

LIMS Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Software
  • Services

LIMS End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Life Sciences
  • CROs
  • Petrochemical Refineries & Oil and Gas Industry
  • Chemical Industry
  • Food and Beverage and Agriculture Industries
  • Environmental Testing Laboratories
  • Other Industries (Forensics and Metal & Mining Laboratories)

LIMS Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

List of Key Players of Laboratory Information Management System (LIMS) Market

  • Thermo Fisher Scientific
  • Siemens
  • LabVantage Solutions Inc.
  • LabWare
  • PerkinElmer Inc.
  • Abbott Laboratories
  • Autoscribe Informatics
  • Illumina, Inc.
  • Labworks
  • LabLynx, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ostomy Care And Accessories Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 Ostomy Care And Accessories Market Growth & Trends 

The global ostomy care and accessories market size is anticipated to reach USD 4.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.1% from 2021 to 2028. The increasing prevalence of bladder and colorectal cancer coupled with the rise in the geriatric population is a key contributor to market growth.

The high prevalence of colorectal cancer and urinary bladder cancer has increased the demand for ostomy care products globally. For instance, as per the estimates of the American Cancer Society, in the U.S., in 2021, around 149,500 people are expected to be diagnosed with colorectal cancer, and approximately 52,980 people are expected to die due to colorectal cancer. This is expected to drive the market over the forecast period.

However, the COVID-19 crisis has been negatively impacted the market. Most projects related to the surgical procedure in South Korea, China, the U.S., and Germany got postponed due to an outbreak of a pandemic. The companies are facing short-term operational issues owing to supply chain constraints (restrictions at international borders). Thus, affecting the market growth in the short term.

The presence of various e-commerce sites offering products related to the surgical procedure might drive the sales of products. Amazon, Stomabags, and Express Medical Supply Inc. are some of the notable e-commerce sites which offer significant discounts, warranty, and prompt customer service on various products and accessories.

Request a free sample copy or view report summary: Ostomy Care And Accessories Market Report

Ostomy Care And Accessories Market Report Highlights

  • Based on product, the ostomy bags segment dominated the market in 2020 with a share of 85.0% owing to increasing cases of urological ailments, such as Inflammatory Bowel Disease, chronic kidney disease, and bladder control problems. The segment is further sub-segmented into one-piece and two-piece bags
  • On the basis of application, the colostomy segment dominated the market in 2020 and accounted for the largest revenue share of 45.8% due to the increasing geriatric population and high prevalence of colorectal cancer
  • Based on end-use, the home care settings segment dominated the market in 2020 and accounted for the largest revenue share of 45.4%, owing to an increase in demand for ostomy care products in the home care and patient-centric healthcare services
  • Europe dominated the market with the highest revenue share of 47.2% in 2020 owing to the high incidence rate of Crohn’s disease and ulcerative colitis in this region and increasing incidence of urological diseases

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ostomy-care-accessories-market

Ostomy Care And Accessories Market Segmentation

Grand View Research has segmented the global ostomy care and accessories market on the basis of product, application, end-use, and region:

Ostomy Care & Accessories Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Bags
    • One Piece
    • Two Piece
  • Accessories
    • Seals/Barrier Rings
    • Pouch Cover
    • Pouch Closures
    • Stoma Caps/Hat
    • Others

Ostomy Care & Accessories Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Colostomy
  • Ileostomy
  • Urostomy

Ostomy Care & Accessories End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Home Care Settings
  • Hospitals
  • Others

Ostomy Care & Accessories Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Ostomy Care And Accessories Market

  • Coloplast Corp.
  • Braun Melsungen AG
  • Hollister Incorporated
  • ConvaTec Group Plc
  • Welland Medical Ltd.
  • Salts Healthcare Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

MicroRNA Market to Partake Significant Development During 2021 to 2028: Grand View Research Inc.

 microRNA Market Growth & Trends

The global microRNA market size is expected to reach USD 3.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.8% from 2021 to 2028. Extensive research activities targeted towards exploring the potential functions of microRNA (miRNA) to design novel therapeutic solutions against different diseases is set to contribute to the adoption of miRNA instruments and consumables. These studies assist in understanding the mechanism of action of the signaling pathway, further integral to develop miRNA drug candidates.

For instance, in June 2020, Munich researchers have discovered that a specific microRNA helps in preserving the integrity of the endothelium and hence reducing the risk of atherosclerosis. Robust funding in biotechnology companies offering miRNA therapeutics is further propelling the influx of miRNA companies. For instance, in February 2021, InteRNA Technologies received a funding of USD 22.46 million in a Series B funding round, led by AurorA Science, an Italian biotech investment company.

The funding will support the clinical evaluation of INT-1B3, its microRNA lead candidate for treating patients with advanced solid tumors. In addition, the grants will help in advancing proprietary preclinical drug candidates for addressing a variety of cancer indications. Moreover, microRNAs (miRNAs) can influence the expression of certain genes, which makes it a potential solution for developing future medicine. Additionally, researchers are exploring the role of micro-RNA in the management of SARS-COV-2 infection. Studies have indicated that miRNAs play a vital role in regulating innate and adaptive immune systems.

Furthermore, studies have shown that the expression of these miRNAs has a role in the host’s response against the coronavirus and other respiratory viruses. Several in-silico experimentations have displayed that miRNA interactions with SARS-CoV-1 cause upregulation of some miRNA such as miR-574-5p, miR-17, and miR-214; helping in the inhibition of viral replication. Hence, studying the changes in miRNA expressions using sequencing instruments can contribute to understanding the pathogenesis of such chronic respiratory infections.

Request a free sample copy or view report summary: microRNA Market Report

microRNA Market Report Highlights

  • The consumables segment accounted for the largest revenue share in 2020 and is expected to continue the trend in the forecast period owing to the use of PCR consumables for facilitating efficient RNA purification and multiple enzymatic steps
  • The instruments segment is expected to witness gradual growth through 2021 to 2028 owing to its high costing and established penetration of PCR instruments for sequencing miRNA
  • The profiling, localization, and quantification instruments segment dominated the market as it is an integral step that is witnessing an influx of technological advancement
  • For instance, the development of bead-based miRNA profiling involves specific oligonucleotide probes which are later detected using flow cytometry
  • The isolation and purification is expected to witness the fastest CAGR through 2021 to 2028 owing to the gaining popularity of studying gene expression for the identification of diseases
  • The infectious disease segment generated the highest revenue in 2020, attributed to a steep increase in the adoption of miRNA isolation and purification kits across COVID-19 research and diagnostic workflows
  • miRNA isolates are emerging as fundamental components to assess SARS-COV-2 infection characteristics
  • They are involved in mechanisms such as alteration in epigenetic regulation, genomic instabilities, biogenesis machinery defects, and aberrant transcriptional control
  • The cardiovascular disease segment is expected to witness a lucrative growth rate of 16.1% owing to the rising application of miRNAs as biomarkers for cardiovascular disorders such as myocardial infarction, atherosclerosis, and coronary artery disease
  • The academic and government research institutes is estimated to hold the largest market share owing to the high adoption of research tools for studying miRNA in research institutes
  • North America emerged as the highest revenue-generating region, capturing more than 45.0% revenue share in 2020 owing to its strong patent base for microRNA
  • Research institutes in the region are conducting extensive research activities to find a link between miRNA and metabolic disorders
  • For instance, in October 2020, a group of researchers from Regents of the University of California discovered that a microRNA is associated with metabolic diseases such as type 2 diabetes obesity, and insulin resistance
  • Asia Pacific is expected to witness lucrative growth through 2021 to 2028 due to developing research infrastructure and involvement of local players in manufacturing kits and reagents

Access Press Release@ https://www.grandviewresearch.com/press-release/global-microrna-market

microRNA Market Segmentation

Grand View Research has segmented the global microRNA market on the basis of products, services, application, end-use, and region:

microRNA Products Outlook (Revenue, USD Million, 2017 - 2028)

  • Instruments
    • By Technology
      • Real Time PCR
      • Microarray
      • NGS
      • Others
    • By Workflow
      • Isolation & Purification
      • Whole Blood
      • Serum
      • Plasma
      • FFPE
      • Fresh Frozen Tissue
      • Others
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis & Others
    • Others
  • Consumables
    • By Specimen
      • Whole Blood
      • Serum
      • Plasma
      • FFPE
      • Fresh Frozen Tissue
      • Others
    • By Workflow
      • Isolation & Purification
      • miRNA cDNA Synthesis
      • Profiling, Localization, & Quantification
      • Functional Analysis
      • Others

microRNA Services Outlook (Revenue, USD Million, 2017 - 2028)

  • Service Type
    • Isolation & Purification
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis
      • Real Time PCR
      • Microarray
      • NGS
      • Others
    • Others
  • By Specimen
    • Whole Blood
    • Serum
    • Plasma
    • FFPE
    • Fresh Frozen Tissue
    • Others

microRNA Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

microRNA End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Other end-users

microRNA Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa

List of Key Players of microRNA (miRNA)Market

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Horizon Discovery Ltd.
  • Synlogic
  • QIAGEN
  • GeneCopoeia, Inc.
  • New England Biolabs
  • Quantabio
  • NanoString
  • BioGenex
  • SeqMatic LLC
  • Miltenyi Biotec
  • Sistemic Scotland Limited
  • Biodynamics Laboratory Inc.
  • OriGene Technologies, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Prosthetics & Orthotics Market Trends Analysis And Forecast Till 2028: Grand View Research Inc.

 Prosthetics & Orthotics Market Growth & Trends

The global prosthetics and orthotics market size is expected to reach USD 8.6 billion by 2028, registering a CAGR of 4.2% over the forecast period, according to a new report by Grand View Research, Inc. Increasing cases of osteosarcoma & sports injuries and a growing geriatric population are the key factors driving the market growth.

The rising geriatric population across the globe has become one of the key factors driving demand for prosthetics and orthotics. For instance, as per the United Nations, globally, the number of people aged 60 years or above is expected to increasing from 962 million in 2017 to 2.1 billion in 2050. People aged 60 years and above are more susceptible to conditions, such as osteoporosis and osteopenia, boosting the demand for various orthopedic solutions.

The increasing incidence of osteosarcoma in young adults and children is also driving the market to a great extent. Patients recovering from this surgery generally need orthopedic devices and prosthetics as a part of post-surgery treatment, which is slated to drive the market in the coming years. As per a study conducted in 2018, around 800 to 900 new cases of osteosarcoma were reported in the U.S. each year.

As per the American Orthotic & Prosthetic Association, at least 11 states in the U.S. and multiple local municipalities had issued orders restricting operations of “non-essential” businesses until further notice during the Covid-19 pandemic. However, healthcare facilities were considered as “essential” services and exempted from the regulations, which is estimated to support market growth.

Request a free sample copy or view report summary: Prosthetics & Orthotics Market Report

Prosthetics & Orthotics Market Report Highlights

  • In terms of revenue, the orthotics segment is projected to ascend at a CAGR of 3.3% over the forecast period
  • Increasing cases of diabetes-related amputations across the globe are acting as the driving factor for the orthotics type segment
  • In terms of revenue, Asia Pacific is expected to exhibit the fastest growth rate over the forecast period
  • An increase in disposable income levels and supportive government initiatives are the key factors augmenting the market growth in Asia Pacific
  • Most of the companies in the market have undertaken various strategies, such as mergers, acquisitions, collaborations, and new product launches, to increase their market share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-prosthetics-orthotics-market

Prosthetics & Orthotics Market Segmentation

Grand View Research has segmented the global prosthetics and orthotics market on the basis of type and region:

Prosthetics & Orthotics Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Prosthetics
    • Upper Extremity
    • Lower Extremity
    • Liners
    • Sockets
    • Modular Components
  • Orthotics
    • Upper Limb
    • Lower Limb
    • Spinal

Prosthetics & Orthotics Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Sweden
    • Denmark
    • Belgium
    • The Netherlands
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

List of Key Players of Prosthetics & Orthotics Market

  • Blatchford, Inc.
  • Fillauer LLC
  • The Ohio Willow Wood Company
  • Ossur
  • Steeper Group
  • Ottobock Healthcare GmbH
  • Ultraflex Systems, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 22 November 2021

Surgical Instrument Tracking Systems Market Predicted to Cross USD 395.7 Million by 2028: Grand View Research Inc.

 Surgical Instrument Tracking Systems Market Growth & Trends

The global surgical instrument tracking systems market size is anticipated to reach USD 395.7 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% from 2021 to 2028. The increasing need for inventory management and implementation of Unique Device Identification (UDI) regulations formed by the FDA are some of the major factors supporting the market growth.

The U.S. regulations required surgical tools to be marked with a UDI by 2020. Most surgical instruments are identified under class I devices by the U.S. FDA. As per the FDA’s June 2020 guidelines, the agency postponed the compliance date for UDI labeling, Direct Mark, GUDID Data Submission, and Standard Date Format to September 2022.

Surgical instrument tracking systems also enable better monitoring by competent authorities while reducing medical errors, thus propelling the demand. The usability of such solutions in inventory management and during the work cycle including surgeries, storage, sterilization procedures, and post-surgery are other drivers contributing to market growth.

A large number of operating rooms and other departments in hospitals collectively require more than 1,000 instruments each day. This has led to a huge need for surgical instrument inventory management, which facilitates assembling and checking the set of tools while saving manpower and time. This is expected to fuel the market growth.

Although the number of elective surgeries plunged during the COVID-19 pandemic, the volume is expected to return to pre-COVID numbers which in turn is estimated to drive the market. Also, the pandemic has a neutral effect on the underlying need for surgical instrument tracking systems and in fact highlights the need for such solutions to track and control infections at hospitals and safeguard patient health.

Request a free sample copy or view report summary: Surgical Instrument Tracking Systems Market Report

Surgical Instrument Tracking Systems Market Report Highlights 

  • The barcode technology segment was the largest revenue-generating segment in 2020 owing to its several advantages such as ease of handling and low installation cost
  • The RFIDsegment is projected to expand at the fastest CAGR during the forecast period due to the growing demand of end-users for technologically advanced instrument traceability and inventory solutions
  • In 2020, the hardware segment grabbed the largest revenue share while the software segment followed close behind. The hardware segment is also expected to witness the highest CAGR over the forecast period
  • The hospitals segment held the largest revenue share in 2020, owing to the increasing adoption of these devices for inventory management and their ability to facilitate better patient safety
  • North America dominated the market in 2020 and is expected to continue its dominance during the forecast period. Highly developed healthcare infrastructure and availability of advanced products is projected to drive the market in the region
  • In Asia Pacific, the market is anticipated to witness a significant CAGR over the next few years.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surgical-instrument-tracking-systems-market

Surgical Instrument Tracking Systems Market Segmentation

Grand View Research has segmented the global surgical instrument tracking systems market on the basis of product, technology, end-use, and region:

Surgical Instrument Tracking Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Hardware
  • Software
  • Services

Surgical Instrument Tracking Systems Technology Outlook (Revenue, USD Million, 2016 - 2028)

  • Barcodes
    • Hospitals
    • Others
  • RFID
    • Hospitals
    • Others

Surgical Instrument Tracking Systems End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Others

Surgical Instrument Tracking Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Surgical Instrument Tracking Systems Market

  • Censis Technologies, Inc.
  • Spatrack Medical Limited
  • Xerafy Singapore Pte Ltd.
  • Fingerprint Medical Limited
  • Getinge AB
  • Braun Melsungen AG
  • BD
  • Haldor Advanced Technologies
  • Microsystems, INC
  • Ternio Group LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Knife Sharpening Service Market Industry Analysis , Opportunity Assessment And Forecast Till 2028: Grand View Research Inc.

 U.S. Knife Sharpening Service Market Growth & Trends

The U.S. knife sharpening service market size is expected to reach USD 117.1 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.5% from 2021 to 2028. The rapid development of urban areas, coupled with consumer preference for a wide variety of cuisines, has led to an increase in the number of cafes, specialty coffee shops, and quick-service restaurants (QSRs) in the U.S. The trend of dining in restaurants and cafes offers lucrative growth opportunities for knife sharpening service providers.

According to the National Restaurant Association, U.S., there were over 1 million restaurant locations in the country in 2019. In addition, the growth of the restaurant industry owing to consumers’ desire for convenience, socialization, and high-quality food and service has resulted in restaurant owners investing in modern and quality kitchen knives. This factor acts as a major driver for the market in the country.

According to the American Barber Association, there are 140,000 businesses providing barbershop services in the U.S. Hence, the growing demand for the sharpening of scissors and blades is driving the need for sharpening service providers.

The increasing influence of culinary arts on consumers, coupled with the growing number of luxury hotels and high-end restaurants, supports the demand for kitchen knife sharpening services in the commercial segment. The growing trend of tourism, coupled with the growing consumer willingness to spend on exploring exotic destinations, luxury hotels, and culinary travels, is also expected to drive the demand for kitchen knives and knife sharpening services in the country.

Hotels, restaurants, barbershops, and lawnmower repair shops are among the major end-users of sharpening services for knives and other cutting tools. In addition, residential households that use high-priced and premium quality knives opt for knife sharpening services in order to enhance the life span of the knife and retain the quality of the blade.

Consumers tend to opt for seasoned knife sharpening service providers with extensive experience in the industry. Moreover, consumers prefer that knives be sharpened on whetstones that typically start off at 1,000 grit and finish anywhere between 6,000 grit and 10,000 grit. The trend of electric sharpeners is also increasing among business owners in order to cater to the rising demand for normal/minor sharpening services. Knife sharpening service providers are opting for electric sharpeners owing to their major benefits, such as low cost and less time consumption.

One of the major factors affecting purchasing decisions is the turnaround time of knives in the market. Moreover, the durability and quality of sharpening are key in influencing consumers’ decisions on whether or not to visit again. Word-of-mouth marketing also significantly affects the purchasing decisions of consumers. In addition, the growing presence of service offerings via social media and e-commerce platforms is influencing and changing the way consumers opt for such services. Several players in the market choose to mail-order services to increase their reach among consumers. New entrants offering various innovative solutions and practices also influence the purchasing decisions of consumers.

The cost of the service is also a major factor affecting the buying decisions of consumers. Consumers with high volume need to seek services at lower costs and with less turnaround time. The growing awareness about the benefits of sharp knives and cutting tools is also driving consumers to opt for professional services instead of at-home or DIY practices. 

Request a free sample copy or view report summary: U.S. Knife Sharpening Service Market Report

U.S. Knife Sharpening Service Market Report Highlights

  • The household end-user segment accounted for the largest share of almost 55.0% in 2020 owing to the increasing urbanization
  • The commercial end-user segment is expected to expand at the fastest CAGR of 6.9% from 2021 to 2028. This is attributed to the rapid expansion of commercial spaces, which is propelling the demand for kitchen tools
  • The Western region of the U.S. held the largest share of 25.5% in 2020 owing to the continuous growth of the housing market

Access Press Release@ https://www.grandviewresearch.com/press-release/us-knife-sharpening-service-market-analysis

U.S. Knife Sharpening Service Market Segmentation

Grand View Research has segmented the U.S. knife sharpening service market on the basis of end-user and region:

U.S. Knife Sharpening Service End-user Outlook (Revenue, USD Million, 2016 - 2028)

  • Household
  • Commercial
  • Industrial

U.S. Knife Sharpening Service Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • Northeast
  • Southwest
  • Midwest
  • West
  • Southeast

List of Key Players of U.S. Knife Sharpening Service Market

  • Carter Cutlery
  • American Cutting Edge, Inc.
  • Cozzini Bros, Inc.
  • Florida Knife Company
  • Town Cutler
  • Eversharp Knives
  • John’s Sharpening Service & Cutlery
  • Market Grinding Inc.
  • National Sharpening Company
  • Rod’s Sharpening Service

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Molecular Diagnostics Market Estimated to Experience a Hike in Growth by 2028: Grand View Research Inc.

 Molecular Diagnostics Market Growth & Trends

The global molecular diagnostics market size is expected to reach USD 49.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2021 to 2028. This growth is owing to factors such as an increasing geriatric population, the outbreak of COVID-19, and the growing demand for point-of-care facilities.

Molecular diagnostics play an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections and infectious diseases is projected to drive the market over the forecast period. Increasing incidence of cardiovascular, neurological, and genetic disorders is further anticipated to accelerate market growth.

The miniaturization of three basic molecular assays - nanobiotechnology, biochips, and microfluidics - is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

Companies expanding their regional presence owing to approval of COVID-19 IVD tests are expected to boost the market growth. For instance, Vela Diagnostics received the CE-IVD mark for ViroKey SARS-CoV-2 RT-PCR Test. It is a probe-based RT-PCR test used on Applied Biosystems 7500 Fast Dx instrument to detect SARS-CoV-2. The CE-IVD mark has enabled Vela diagnostics to expand its COVID-19 test in Europe.

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the market. 

Request a free sample copy or view report summary: Molecular Diagnostics Market Report

Molecular Diagnostics Market Report Highlights

  • The reagents segment dominated the market majorly driven by the high usage rate
  • The PCR technology segment accounted for the highest revenue share in 2020, attributable to its wide usage in the diagnosis of COVID-19 and other infectious diseases
  • The self-testing or OTC segment is anticipated to be the fastest-growing segment over the forecast period as it facilitates early diagnosis and constant patient monitoring
  • North America accounted for the highest revenue share in 2020, driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-molecular-diagnostics-market

Molecular Diagnostics Market Segmentation

Grand View Research has segmented the global molecular diagnostics market based on product, test location, technology, application, and region:

Molecular Diagnostics Product Outlook (Revenue, USD Million, 2017 - 2028)

  • Instruments
  • Reagents
  • Others

Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2017 - 2028)

  • Point-of-Care
  • Self-test or Over the Counter
  • Central Laboratories

Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2017 - 2028)

  • Polymerase Chain Reaction (PCR)
    • PCR, By Type
      • Multiplex PCR
      • Other PCR
    • PCR, By Product
      • Instruments
      • Reagents
      • Others
    • PCR, By Procedure
      • Nucleic Acid Extraction and Purification
      • Others
    • In Situ Hybridization (ISH)
      • Instruments
      • Reagents
      • Others
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Instruments
      • Reagents
      • Others
    • Chips and Microarrays
      • Instruments
      • Reagents
      • Others
    • Mass Spectrometry
      • Instruments
      • Reagents
      • Others
    • Sequencing
      • Instruments
      • Reagents
      • Others
    • Transcription Mediated Amplification (TMA)
      • Instruments
      • Reagents
      • Others
    • Others
      • Instruments
      • Reagents
      • Others

Molecular Diagnostics Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Oncology
    • Breast Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Kidney Cancer
    • Liver Cancer
    • Blood Cancer
    • Lung Cancer
    • Other Cancer
  • Pharmacogenomics
  • Infectious Diseases
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
    • Clostridium Difficile
    • Vancomycin-resistant Enterococci (VRE)
    • Carbapenem-resistant Bacteria
    • Flu
    • Respiratory Syncytial Virus (RSV)
    • Candida
    • Tuberculosis and Drug-resistant TB
    • Meningitis
    • Gastrointestinal Panel Testing
    • Chlamydia
    • Gonorrhea
    • HIV
    • Hepatitis C
    • Hepatitis B
    • Other Infectious Disease
  • Genetic Testing
    • Newborn Screening
    • Predictive and Presymptomatic Testing
    • Other Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others

Molecular Diagnostics Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Belgium
    • Switzerland
    • Netherlands
    • Poland
    • Austria
    • Greece
    • Sweden
    • Turkey
    • Finland
  • Asia Pacific
    • Japan
    • China
    • India
    • Sri Lanka
    • Malaysia
    • Australia
    • New Zealand
    • Thailand
    • Vietnam
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Chile
    • Peru
    • Colombia
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Jordan
    • UAE
    • Qatar
    • Nigeria
    • Egypt

List of Key Players of Molecular Diagnostics Market

  • BD
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic Inc. (Gen-Probe)
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Grifols, S.A.
  • QIAGEN
  • Hoffmann-La Roche, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

License Management Market Size, Trends, and Growth Forecast 2033

  License management is the process of tracking, organizing, and controlling software licenses within an organization. As businesses increas...